Bence Kapuvári

In-vivo antitumour effect of daunorubicin–GnRH-III derivative conjugates on colon carcinoma-bearing mice

G. Mező, J. Tóvári, M. Manea, 2012, Anti-cancer drugs.

Synthesis and structural characterization of bioactive peptide conjugates using thioether linkage approaches

M. Przybylski, F. Hudecz, G. Mezö, 2004, Journal of peptide science : an official publication of the European Peptide Society.

Enhanced enzymatic stability and antitumor activity of daunorubicin-GnRH-III bioconjugates modified in position 4.

G. Mező, A. Marquardt, Ulrike Leurs, 2011, Bioconjugate chemistry.

Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice

G. Mező, C. Steinkühler, S. Schuster, 2019, International journal of molecular sciences.

Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice

G. Mező, Rózsa Hegedüs, J. Tóvári, 2016, Investigational New Drugs.

Development of an oxime bond containing daunorubicin-gonadotropin-releasing hormone-III conjugate as a potential anticancer drug.

M. Przybylski, S. Bősze, A. Csámpai, 2009, Bioconjugate chemistry.

Structure, enzymatic stability and antitumor activity of sea lamprey GnRH-III and its dimer derivatives

O. Csuka, M. Przybylski, A. Perczel, 2007, Peptides.

Local immune parameters as potential predictive markers in head and neck squamous cell carcinoma patients receiving induction chemotherapy and cetuximab

É. Remenár, A. Ladányi, J. Lövey, 2018, Head & neck.

Serum estrone concentration, estrone sulfate/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinoma

I. Láng, Z. Horváth, N. Udvarhelyi, 2015, SpringerPlus.

Sequence modification of heptapeptide selected by phage display as homing device for HT-29 colon cancer cells to improve the anti-tumour activity of drug delivery systems.

R. Szabó, G. Mező, Gitta Schlosser, 2019, European journal of medicinal chemistry.